Kezar Life Sciences, Inc. (KZR) Other financing activities (2018 - 2026)

Kezar Life Sciences (KZR) posted Other financing activities of $267000.0 for Q1 2026, up 790.0% sequentially from $30000.0 in Q4 2025.

Kezar Life Sciences, Inc. (KZR) Other financing activities (2018 - 2026) Analysis & Trends

Kezar Life Sciences has reported Other financing activities for 9 years, with the latest figure at $267000.0 in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $267000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $332000.0 (up 222.33% YoY) and the FY2025 annual result came in at $65000.0, down 36.89% from the prior year.
Other financing activities rose to $267000.0 in Q1 2026 per KZR's latest filing, from $30000.0 in the prior quarter.
Over five years, Other financing activities peaked at $506000.0 in Q4 2022 and troughed at $30000.0 in Q4 2025.
A 5-year average of $184000.0 and a median of $154000.0 in 2023 frame the typical range for Other financing activities.
The sharpest annual moves came in 2022 and 2023: Other financing activities surged 232.26% in 2022, then tumbled 88.34% in 2023.
Over 5 years, Other financing activities stood at $506000.0 in 2022, then sank by 88.34% to $59000.0 in 2023, then dropped by 20.34% to $47000.0 in 2024, then slumped by 36.17% to $30000.0 in 2025, then surged by 790.0% to $267000.0 in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $267000.0, $30000.0, and $35000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

Download Data